Position in MRK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$6,609,140
-$2,242,135 QoQ
Shares Held
51,433
-54.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#920
of 3,769 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. MRK ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,248 | $18,683,766 | |
| 2 | LLY |
ELI LILLY & Co
|
8,310 | $9,967,264 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
57,007 | $7,202,264 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
51,433 | $6,609,140 | |
| 5 | NVO |
Novo Nordisk A S
|
86,018 | $4,123,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,615 | $2,685,956 | |
| 7 | AMGN |
Amgen Inc
|
5,281 | $1,912,355 | |
| 8 | GSK |
GSK plc
|
24,289 | $1,273,229 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,609,140 | 51,433 | Shares | Sole | 2026-07-14 | |
| 2025-06-30 | $8,851,275 | 111,815 | Shares | Sole | 2025-08-01 | |
| 2024-03-31 | $2,251,858 | 17,066 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,724,160 | 116,714 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $1,826,822 | 17,171 | Shares | Sole | 2023-05-09 | |
| 2022-09-30 | $362,479 | 4,209 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $2,577,272 | 31,411 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $227,237 | 2,965 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $392,116 | 5,042 | Shares | Sole | 2021-08-26 | |
| 2020-12-31 | $749,042 | 9,157 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||